English | Español

Allergan, Inc.
Ruth de Jauregui | Apr 22, 2017

Novartis teaming with Allergan in Phase IIb trial of non-alcoholic steatohepatitis treatment therapy
Tabitha Fleming | Jan 24, 2017

Allergan continues support for headache research

Jamie Barrand | Mar 20, 2016

New treatment available for bipolar disorder, schizophrenia
Jamie Barrand | Mar 17, 2016

Allergan's dry eye disease therapy receives prior approval supplement from FDA
Jamie Barrand | Dec 17, 2015

Allergan releases new therapy for irritable bowel syndrome
Jamie Barrand | Dec 7, 2015

Allergan partners with Rugen Therapeutics to develop autism, OCD therapies
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215
Jamie Barrand | Oct 14, 2015

Allergan releasing generic version of Invega in U.S.

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program
+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’